1. Home
  2. VLRS vs ESPR Comparison

VLRS vs ESPR Comparison

Compare VLRS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$7.77

Market Cap

897.4M

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLRS
ESPR
Founded
2005
2008
Country
Mexico
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
897.4M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VLRS
ESPR
Price
$7.77
$3.79
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$8.43
$6.86
AVG Volume (30 Days)
440.5K
6.5M
Earning Date
10-27-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,990,662,000.00
$303,802,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
$11.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.83
52 Week Low
$3.49
$0.69
52 Week High
$9.00
$4.13

Technical Indicators

Market Signals
Indicator
VLRS
ESPR
Relative Strength Index (RSI) 63.41 58.42
Support Level $7.32 $3.72
Resistance Level $7.88 $4.13
Average True Range (ATR) 0.30 0.26
MACD 0.04 -0.00
Stochastic Oscillator 84.78 59.74

Price Performance

Historical Comparison
VLRS
ESPR

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: